medicine

Ep 03 When The Medicine Says No

Show Notes

In this episode, I dive into the recent developments in the psychedelic world, exploring the FDA advisory panel’s surprising vote against the use of MDMA for treating PTSD. Join us as I unpack the implications of this decision and reflect on what it means for the future of psychedelic therapy.

To put it in context, I provide a little historical back story on how MDMA became a Schedule I drug. I then discuss the history of MAPS and their tireless work to bring MDMA back into the therapeutic world as a legal medicine.

I talk about the wisdom of the medicine, lessons on integrity, ethical standards, and the importance of accountability in psychedelic therapy. Finally, I explore the difference between intention and expectation in psychedelic experiences and how the medicine can often say no to us when we show up with an expectation instead of an open-minded intention.

Until next time, keep exploring and growing together!

Links:

The Psychedelic Report Podcast: Understanding the Impact of the FDA Vote on MDMA Therapy with Dr. Dave Rabin and Rachel Nuwer

 

Jules Evans/Ecstatic Integration: The Psychedelic Field Starts to Publicly Acknowledge Adverse Events

 

New York Times Overview of FDA Advisory Panel Decision

 

New York Magazine’s Podcast uncovering sexual exploitation in the psychedelic underground

Share the Podcast

About

Picture of Carla Detchon
Carla Detchon

Honoring feminine-focused 👩🏻‍🤝‍👩🏿voices & power🙋‍♀️ in the psychedelic realm in service of growth, transformation 🍄inner truth & our divinity🙏

Let’s Get Social!

More Podcast Episodes

Podcast

Ep 05 Restoring the Sacred with Dream Mullick

In this episode of Psychedelic Divas, the multi-talented Dream Mullick shares her diverse experiences and insights spanning writing, teaching, producing, and death coaching. Dream shares her journey from co-producing the Psychedelic Integration Conference at Esalen to her upcoming documentary on Rick Doblin’s mission to legalize MDMA.

Read more
Podcast

Ep 04 From Menstruation to Menopause—Psychedelics & Women’s Health

In this episode, we explore the role psychedelics, especially ketamine, can play in women’s health from menstruation to menopause. Psychotherapist Melissa Whippo shares her history working with women both before and after birth to help them with anxiety, depression and other mood disorders. Melissa was behind the first study to determine whether ketamine was safe for lactating mothers. To put it in context, I provide a little historical back story on how MDMA became a Schedule I drug. I then discuss the history of MAPS and their tireless work to bring MDMA back into the therapeutic world as a legal medicine.
I talk about the wisdom of the medicine, lessons on integrity, ethical standards, and the importance of accountability in psychedelic therapy. Finally, I explore the difference between intention and expectation in psychedelic experiences and how the medicine can often say no to us when we show up with an expectation instead of an open-minded intention.

Read more
Podcast

Ep 02 How Guided Psychedelic Journeys Changed My Life

What’s a nice girl from the Midwest doing with an underground psychedelic guide? (Thanks for the inspiration, Michael Pollan!)

The good, the bad and the transcendent—Sheri discusses her various journeys and the messages she received.
Sheri and Carla discuss the various merits of snorting versus smoking 5-meO-DMT.
The power of integration. Sheri shares how she integrated the messages and visions from her journeys in order to uplevel her vibration—and her life!

Read more

RECEIVE YOUR FREE GUIDE:

“PSYCHEDELIC SAFETY TIPS INCLUDING WHAT TO DO WHEN THINGS GO WRONG”